Previous 10 | Next 10 |
2024-04-25 21:45:15 ET Image source: The Motley Fool. Gilead Sciences (NASDAQ: GILD) Q1 2024 Earnings Call Apr 25, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript
2024-04-25 20:26:05 ET Gilead Sciences, Inc. (GILD) Q1 2024 Earnings Conference Call April 25, 2024, 04:30 PM ET Company Participants Jacquie Ross - Vice President, Investor Relations Daniel O'Day - Chairman and Chief Executive Officer Johanna Mercier - Chief Com...
2024-04-25 18:55:25 ET More on Gilead Sciences Gilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern? Gilead Sciences: Some Signs Of An Impending Bottom Gilead Sciences Finally Starts Succeeding Gilead Sciences Non-GAAP EPS of -$1.32 beats by $...
2024-04-25 17:49:16 ET Summary The Annual Meeting of the American Society of Clinical Oncology is a major event for clinicians and researchers in the field of oncology. The plenary session will feature presentations on topics such as esophageal cancer, melanoma, and lung cancer. ...
2024-04-25 16:19:35 ET More on Gilead Sciences Gilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern? Gilead Sciences: Some Signs Of An Impending Bottom Gilead Sciences Finally Starts Succeeding Gilead Sciences Q1 Preview: HIV pipeline, FY24 gu...
2024-04-25 16:04:59 ET More on Gilead Sciences Gilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern? Gilead Sciences: Some Signs Of An Impending Bottom Gilead Sciences Finally Starts Succeeding Gilead Sciences Q1 Preview: HIV pipeline, FY24 gu...
Product Sales Excluding Veklury Increased 6% Year-Over-Year to $6.1 billion Biktarvy Sales Increased 10% Year-Over-Year to $2.9 billion Oncology Sales Increased 18% Year-Over-Year to $789 million Closed CymaBay Acquisition Resulting in $3.9 billion Acquired IPR&D Charg...
2024-04-25 08:10:00 ET Summary Global stock indices continued an upward trend in March, with both U.S. and non-U.S. stocks rising by 3%. Nvidia unveils groundbreaking Blackwell chip at GTC 2024, CEO predicts AI's influence will expand across all facets of life. Portfolio chang...
2024-04-25 08:00:00 ET Summary Polaris Capital Management, LLC is a leading global value equity manager, serving the investment needs of institutions and individuals since 1995. Polaris has one of the longest global and international equity track records of any firm presently in opera...
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...
News, Short Squeeze, Breakout and More Instantly...
– RADIAN’s Five-Year, $25 Million Extension Will Increase Support for Local Organizations and Drive Progress to Help Turn the Tide on HIV Across the Region – – RADIAN Will Expand Geographic Focus to Provide Key Populations and Communities Im...
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Chief Medical Officer Merdad Parsey, MD, PhD, will leave the company early next year. While the company works to identify a successor, Dr. Parsey will continue as Chief Medical Officer until the first quarter of 2025 and support this trans...